Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Familial Hypophosphatemic Rickets × burosumab × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

Oncogenic osteomalacia 4 Nevus, Sebaceous of Jadassohn 4 Familial Hypophosphatemic Rickets 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03775187 2025-03-05

Expanded Access to Burosumab

Kyowa Kirin Co., Ltd.

Oncogenic osteomalacia, Familial Hypophosphatemic Rickets

Data powered by HemOnc (CC BY 4.0) Colophon ⚡